0000899243-17-008150.txt : 20170317
0000899243-17-008150.hdr.sgml : 20170317
20170317203609
ACCESSION NUMBER: 0000899243-17-008150
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170315
FILED AS OF DATE: 20170317
DATE AS OF CHANGE: 20170317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001422142
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 611547850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
BUSINESS PHONE: (513) 985-1920
MAIL ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP II
DATE OF NAME CHANGE: 20071227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NOVARTIS AG
CENTRAL INDEX KEY: 0001114448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53057
FILM NUMBER: 17699884
BUSINESS ADDRESS:
STREET 1: LICHTSTRASSE 35
CITY: BASEL
STATE: V8
ZIP: CH 4056
BUSINESS PHONE: 01141613241111
MAIL ADDRESS:
STREET 1: LICHTSTRASSE 35
CITY: BASEL
STATE: V8
ZIP: CH 4056
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novartis Bioventures Ltd
CENTRAL INDEX KEY: 0001297709
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53057
FILM NUMBER: 17699885
BUSINESS ADDRESS:
STREET 1: C/O NOVARTIS INTERNATIONAL AG
STREET 2: WSJ-200.220
CITY: CH-4002 BASEL
STATE: V8
ZIP: 0000000000
BUSINESS PHONE: 41-61-324-6210
MAIL ADDRESS:
STREET 1: C/O NOVARTIS INTERNATIONAL AG
STREET 2: WSJ-200.220
CITY: CH-4002 BASEL
STATE: V8
ZIP: 0000000000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-15
0
0001422142
Aerpio Pharmaceuticals, Inc.
NONE
0001297709
Novartis Bioventures Ltd
C/O NOVARTIS INTERNATIONAL
AG WSJ-200.220
BASEL
V8
CH-4002
SWITZERLAND
0
0
1
0
0001114448
NOVARTIS AG
LICHTSTRASSE 35
BASEL
V8
CH 4056
SWITZERLAND
0
0
1
0
Common Stock
2017-03-15
4
P
0
560000
5.00
A
5805550
I
See Footnote
The board of directors of Novartis Bioventures Ltd. has sole voting and investment control and power over such securities. None of the members of its board of directors has individual voting or investment power with respect to such securities and each disclaims beneficial ownership of such securities. Novartis Bioventures Ltd. is an indirectly owned subsidiary of Novartis AG.
/s/ Simon Zivi, Chairman /s/ Laurieann Chaikowsky, Authorized signatory
2017-03-17
/s/ Simon Zivi, Authorized signatory /s/ Laurieann Chaikowsky, Authorized signatory
2017-03-17